Literature DB >> 18976290

Molecular correlates of scarring in kidney transplants: the emergence of mast cell transcripts.

M Mengel1, J Reeve, S Bunnag, G Einecke, B Sis, T Mueller, B Kaplan, P F Halloran.   

Abstract

In the Banff consensus, infiltrates in areas of scarring are ignored. This study aimed to characterize the molecular correlates and clinical significance of scarring and inflammation in scarred areas. We assessed the extent of interstitial infiltrates, tubulitis and scarring in 129 clinically indicated renal allograft biopsies, and correlated the results with microarray expression data and allograft survival. Findings were validated in 50 additional biopsies. Transplants with scarring had a worse prognosis if the scarred area showed infiltrates. Infiltration in unscarred and scarred areas was associated with reduced death censored graft survival. In microarray analysis, infiltration in unscarred areas strongly (>r +/- 0.4) correlated with 484 transcripts associated with cytotoxic T cells, interferon-gamma, macrophages and injury. Scarring correlated with a distinct set of 172 transcripts associated with B cells, plasma cells, and others of unknown significance. The strongest correlation was with four mast cell transcripts. In biopsies with scarring, high expression of mast cell transcripts was associated with reduced graft survival and poor functional recovery. In renal allograft biopsies, infiltrates in scarred areas have implications for poor outcomes. Scarring is associated with a distinct pattern of inflammatory molecules, including B cell/immunoglobulin but particularly mast cell-associated transcripts, which correlated with poor outcomes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18976290     DOI: 10.1111/j.1600-6143.2008.02462.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  29 in total

Review 1.  Molecular diagnostics in transplantation.

Authors:  Maarten Naesens; Minnie M Sarwal
Journal:  Nat Rev Nephrol       Date:  2010-08-24       Impact factor: 28.314

Review 2.  Integrative analysis of -omics data and histologic scoring in renal disease and transplantation: renal histogenomics.

Authors:  Paul Perco; Rainer Oberbauer
Journal:  Semin Nephrol       Date:  2010-09       Impact factor: 5.299

3.  Progressive histological damage in renal allografts is associated with expression of innate and adaptive immunity genes.

Authors:  Maarten Naesens; Purvesh Khatri; Li Li; Tara K Sigdel; Matthew J Vitalone; Rong Chen; Atul J Butte; Oscar Salvatierra; Minnie M Sarwal
Journal:  Kidney Int       Date:  2011-08-31       Impact factor: 10.612

Review 4.  Detecting adaptive immunity: applications in transplantation monitoring.

Authors:  Georg A Böhmig; Markus Wahrmann; Marcus D Säemann
Journal:  Mol Diagn Ther       Date:  2010-02-01       Impact factor: 4.074

Review 5.  Biomarkers to detect rejection after kidney transplantation.

Authors:  Vikas R Dharnidharka; Andrew Malone
Journal:  Pediatr Nephrol       Date:  2017-06-19       Impact factor: 3.714

Review 6.  Current pathological perspectives on chronic rejection in renal allografts.

Authors:  Shigeo Hara
Journal:  Clin Exp Nephrol       Date:  2016-11-16       Impact factor: 2.801

7.  Relationships among injury, fibrosis, and time in human kidney transplants.

Authors:  Jeffery M Venner; Konrad S Famulski; Jeff Reeve; Jessica Chang; Philip F Halloran
Journal:  JCI Insight       Date:  2016-01-21

Review 8.  Kidney Fibrosis: Origins and Interventions.

Authors:  Thomas Vanhove; Roel Goldschmeding; Dirk Kuypers
Journal:  Transplantation       Date:  2017-04       Impact factor: 4.939

Review 9.  Molecular assessment of disease states in kidney transplant biopsy samples.

Authors:  Philip F Halloran; Konrad S Famulski; Jeff Reeve
Journal:  Nat Rev Nephrol       Date:  2016-06-27       Impact factor: 28.314

Review 10.  Basophils and mast cells in renal injury.

Authors:  Matthias Mack; Alexander R Rosenkranz
Journal:  Kidney Int       Date:  2009-08-19       Impact factor: 10.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.